We are live on ! Find out more
RLAY icon

Relay Therapeutics
RLAY

177 hedge funds and large institutions have $1.41B invested in Relay Therapeutics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 57 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 25

28% more capital invested

Capital invested by funds: $1.1B → $1.41B (+$312M)

3% more funds holding

Funds holding: 172 → 177 (+5)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 57

3% less ownership

Funds ownership: 106.82% → 103.82% (-3%)

28% less call options, than puts

Call options by funds: $72K | Put options by funds: $100K

Holders
177
Holders Change
+5
Holders Change %
+2.91%
% of All Funds
2.58%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
33
Increased
55
Reduced
57
Closed
25
Calls
$72K
Puts
$100K
Net Calls
-$28K
Net Calls Change
-$117K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$13.5M
2
Norges Bank
Norges Bank
Norway
+$13.2M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$11.4M
4
BlackRock
BlackRock
New York
+$10.5M
5
BG
Bellevue Group
Switzerland
+$8.87M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$35M
2
PA
Perceptive Advisors
New York
-$16.3M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$12.2M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$9.31M
5
Citadel Advisors
Citadel Advisors
Florida
-$9.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$9.08M +$194K +22,992 +3%
T. Rowe Price Investment Management
27
T. Rowe Price Investment Management
Maryland
$8.97M -$12.2M -1,448,546 -64%
CS
28
Candriam SCA
Luxembourg
$7.94M -$2.11M -250,000 -26%
RSCM
29
Rock Springs Capital Management
Maryland
$7.42M – – –
IHAM
30
Integral Health Asset Management
New York
$6.61M -$1.69M -200,000 -25%
Citadel Advisors
31
Citadel Advisors
Florida
$6.58M -$9.16M -1,085,255 -64%
DCM
32
Driehaus Capital Management
Illinois
$6.53M – – –
Bessemer Group
33
Bessemer Group
New Jersey
$6.43M – – –
TD Asset Management
34
TD Asset Management
Ontario, Canada
$5.15M -$249K -29,524 -6%
Ameriprise
35
Ameriprise
Minnesota
$5.06M +$3.07M +364,327 +383%
Two Sigma Investments
36
Two Sigma Investments
New York
$4.46M +$35.8K +4,243 +1%
RPAM
37
Rhenman & Partners Asset Management
Sweden
$4.29M +$1.69M +200,000 +105%
Baillie Gifford & Co
38
Baillie Gifford & Co
United Kingdom
$4.11M -$176K -20,854 -5%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$3.63M +$206K +24,400 +8%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$3.61M -$424K -50,197 -13%
Renaissance Technologies
41
Renaissance Technologies
New York
$3.56M +$1.51M +179,000 +124%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$3.55M -$3.87K -459 -0.1%
Bank of America
43
Bank of America
North Carolina
$3.44M +$404K +47,836 +18%
AAA
44
Affinity Asset Advisors
New York
$3.3M +$2.53M +300,000 New
HP
45
Harbourvest Partners
Massachusetts
$3.26M – – –
Barclays
46
Barclays
United Kingdom
$3.25M +$669K +79,316 +37%
CANY
47
Caxton Associates (New York)
New York
$3.07M +$2.04M +241,247 +637%
N
48
Nuveen
North Carolina
$2.88M +$28.8K +3,413 +1%
WP
49
Woodline Partners
California
$2.75M – – –
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.63M -$8.78K -1,040 -0.4%
1
2
3 4 5

RLAY Hedge Fund Activity: Q4 2023 in Review

177 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Relay Therapeutics (RLAY) for Q4 2023, worth a combined $1.41B — up 28% from $1.1B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new RLAY positions and 25 closed out — a net gain of 8 holders — while 55 added to existing stakes and 57 trimmed.

The largest buyer was BVF Inc, adding an estimated $13.5M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $35M sold.

  • 177 institutional investors held Relay Therapeutics (RLAY) as of Q4 2023, up from 172 in Q3 2023.
  • Funds reported $1.41B of Relay Therapeutics stock for Q4 2023, up 28% quarter-over-quarter.
  • 33 funds opened new Relay Therapeutics positions in Q4 2023 and 25 closed out, a net change of +8 holders.
  • The largest Relay Therapeutics buyer in Q4 2023 was BVF Inc, an estimated $13.5M added.
  • The largest Relay Therapeutics seller in Q4 2023 was EcoR1 Capital, an estimated $35M sold.

Based on aggregated 13F filings for Q4 2023.